Has Gordon Beardwood, MD received payments from drug or device companies?

Yes. Drug and device makers reported $9,186 in general payments to Gordon Beardwood, MD across 123 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Gordon Beardwood, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Gordon Beardwood, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Gordon Beardwood, MD

Pain Medicine · Minneapolis, MNNPI 1316938038

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 93.1% of the total across 123 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Abbott at 38.5% of the total. Reporting peaked in 2021 at $2,998 and has fallen 89.3% since, to $322 in 2025.

$9,186in general payments, 2019–2025

Across 123 payments — averaging $74.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$4K
Boston Scientific$3K
Medtronic$2K
Nevro Corp.$211
Saluda Medical Americas, Inc.$196
Biotronik NRO, Inc.$188
plus $146 from 2 others

What the payments were for

Travel & lodging$5286%
Food & beverage$8,55193%
Education$1071%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	61	$3,536
Boston Scientific	27	$2,751
Medtronic(2 entities)	23	$2,158
Nevro Corp.	4	$211
Saluda Medical Americas, Inc.	2	$196
Biotronik NRO, Inc.	4	$188
Nalu Medical, Inc.	1	$134
Teva Pharmaceuticals USA, Inc.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Proclaim Family of SCS IPGs$1,538
INTELLIS$1,166
WAVEWRITER ALPHA$1,072
WaveWriter Alpha Prime 16$781
GENERAL PAIN MANAGEMENT$269
Proclaim IPG$238
VANTA ADAPTIVESTIM$164
ETERNA$152
SYNCHROMEDII$150
SYNCHROMED$150
NA$135
Nalu Neurostimulation System$134
PROCLAIM$134
Prospera$118
Evoke$117
Senza Spinal Cord Stimulation System$111
Vanta$102

How this compares

$9,186 in reported general payments places this provider in the 80th percentile of 88 pain medicine providers in Minnesota.

See all pain medicine providers in Minnesota →

Medicare billing

Part B allowed, 2024

$30,466

Medicare patients

Services billed

367

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
BelbucaBuprenorphine Hcl	27	$22,714
OxycontinOxycodone Hcl	27	$15,079
Gabapentin	147	$1,852
Levetiracetam	96	$1,453
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	50	$1,119
Zonisamide	82	$1,038
Pregabalin	41	$513
Tizanidine Hcl	23	$345
Diclofenac Sodium	14	$312
Cyclobenzaprine Hcl	17	$297
Oxycodone Hcl	20	$216
Meloxicam	26	$116
Methylprednisolone	13	$83
Tramadol Hcl	13	$46

Paid to pharmacies, not to this prescriber.

Other pain medicine in Minneapolis

Byungkwan HwangMinneapolis$22K
Mihir JoshiMinneapolis$7K
Christina WiekampMinneapolis$5K
Cody TidwellMinneapolis$2K
Ellen DzierzakMinneapolis$1K
Jacob DeweerthMinneapolis$1K
Vasudha GoelMinneapolis$1K
Richard StaynerEdina$105K
David SchultzEdina$99K
Jonathan HagedornRochester$83K

See the full list for Minnesota →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →